10:49 AM EST - Aralez Pharmaceuticals Inc. : Announced the commercial launch of BLEXTEN™ (Bilastine 20 mg oral tablet) for the treatment of the symptoms of Seasonal Allergic Rhinitis (SAR) and Chronic Spontaneous Urticaria (CSU) (such as itchiness and hives) in Canada. Aralez Pharmaceuticals Inc.
shares T.ARZ are trading down $0.01 at $6.47.
